123). It truly is notable that GLS2 is tumorigenic in breast cancer124, and its expression could compensate for loss of Gls in MYC-induced mouse liver tumours40. This suggests that GLS2 could confer resistance to GLS1-particular inhibitors, including the allosteric inhibitor BPTES or CB-839, and this resistance could possibly be hypothetically https://evanse334sdn6.tnpwiki.com/user